A5059173216- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Stroke Rehabilitation and Recovery
- Acute Ischemic Stroke Management
- Mental Health Treatment and Access
- Rheumatoid Arthritis Research and Therapies
- Botulinum Toxin and Related Neurological Disorders
- Intracerebral and Subarachnoid Hemorrhage Research
- COVID-19 and healthcare impacts
- SARS-CoV-2 and COVID-19 Research
- Long-Term Effects of COVID-19
- Venous Thromboembolism Diagnosis and Management
- Bipolar Disorder and Treatment
- Child and Adolescent Psychosocial and Emotional Development
- Neurological Complications and Syndromes
- Polyomavirus and related diseases
Iran University of Medical Sciences
2021-2024
Firoozgar General Hospital
2024
Previous studies have mainly focused on individual mental disorders, and there is no study addressing the total burden of disorders in Middle East North Africa (MENA).
Abstract Background Choosing a safe disease modifying therapy during the COVID-19 pandemic is challenging. This case series study was conducted to determine incidence rate and course of Covid-19 infection in MS/NMOSD patients treated with Rituximab. Methods In this study, we designed web-based questionnaire. Baseline information such as patient- reported walking disability, total number Rituximab infusions received, delayed injections, occurrence any relapse, use corticosteroids were...
Abstract Background Coronavirus Disease 2019 (COVID-19) is predominately known as a respiratory disease associated with pneumonia, acute distress syndrome and multiorgan failure. However, extra-pulmonary complications of severe coronavirus 2 (SARS-CoV-2) are increasingly being recognized. In this regard, some studies implied the hemostatic vascular involvements in patients SARS-CoV-2 infection. Case presentation We describe case spontaneous Intracerebral Hemorrhage (ICH) pregnant patient...
Abstract Background Recombinant tissue plasminogen activator (rtPA), the gold standard treatment of acute ischemic stroke, can reportedly result in seizures, known as post-stroke seizure (PSS). PSS is categorized early (EPSS), occurring within first week stroke onset, and late (LPSS), after onset. Therefore, we aimed to evaluate incidence intravenous thrombolysis (IVT) with rtPA identify potentially associated risk factors. Methods This retrospective cohort study included 955 patients who...
Background: The onset-to-arrival time affects the decision of intravenous thrombolysis therapy which is associated with stroke’s prognosis. This study aimed to evaluate factor early and late arrival patients Acute Ischemic Stroke effect on patients’ outcomes. Materials Methods: Patients confirmed acute ischemic stroke in central centers were included a prospective study. grouped into arrivers (less than 4.5 hours) (at after hours). Patients’ data obtained from registry system. Results: In...